{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:30:07Z","timestamp":1788316207330,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s42000-021-00324-z","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T01:02:27Z","timestamp":1634778147000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lipoatrophy, a rare complication of diabetes: a single-center experience"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8834-9642","authenticated-orcid":false,"given":"Maria","family":"Xatzipsalti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hlias","family":"Alvertis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannoula","family":"Kourousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Patouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiris","family":"Konstantakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Delis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriani","family":"Vazeou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"issue":"6230","key":"324_CR1","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1136\/bmj.280.6230.1500","volume":"280","author":"WG Reeves","year":"1980","unstructured":"Reeves WG, Allen BR, Tattersall RB (1980) Insulin-induced lipoatrophy: evidence for an immune pathogenesis. BMJ 280(6230):1500\u20131503","journal-title":"BMJ"},{"issue":"2","key":"324_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1517\/14740330903496402","volume":"9","author":"A Holstein","year":"2010","unstructured":"Holstein A, Stege H, Kovacs P (2010) Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature. Expert Opin Drug Saf 9(2):225\u2013231","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"324_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/adc.2010.183731","volume":"96","author":"A Babiker","year":"2011","unstructured":"Babiker A, Datta V (2011) Lipoatrophy with insulin analogues in type I diabetes. Arch Dis Child 96(1):101\u2013102","journal-title":"Arch Dis Child"},{"issue":"1","key":"324_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-5996-3-33","volume":"3","author":"EA Chantelau","year":"2011","unstructured":"Chantelau EA, Praetor R, Praetor J, Poll LW (2011) Relapsing insulin-induced lipoatrophy, cured by prolonged low-dose oral prednisone: a case report. Diabetol Metab Syndr 3(1):33","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"324_CR5","first-page":"322","volume":"24","author":"AE Renold","year":"1957","unstructured":"Renold AE, Winegrad AI, Martin DB (1957) Diabetes mellitus and the adipose tissue. Helv Med Acta 24(4):322\u2013327","journal-title":"Helv Med Acta"},{"issue":"1","key":"324_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/pedi.12058","volume":"15","author":"AL Rosenbloom","year":"2014","unstructured":"Rosenbloom AL (2014) Insulin injection lipoatrophy recidivus. Pediatr Diabetes 15(1):73\u201374","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"324_CR7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/bjd.13077","volume":"171","author":"GU Sawatkar","year":"2014","unstructured":"Sawatkar GU, Kanwar AJ, Dogra S, Bhadada SK, Dayal D (2014) Spectrum of cutaneous manifestations of type 1 diabetes mellitus in 500 South Asian patients. Br J Dermatol 171(6):1402\u20131406","journal-title":"Br J Dermatol"},{"issue":"4","key":"324_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1055\/s-0034-1394381","volume":"123","author":"E Binder","year":"2015","unstructured":"Binder E, Lange O, Edlinger M, Meraner D, Abt D, Moser C et al (2015) Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 123(4):260\u20134","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"324_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/1932296814558348","volume":"9","author":"O Kordonouri","year":"2015","unstructured":"Kordonouri O, Biester T, Schnell K, Hartmann R, Tsioli C, Fath M et al (2015) Lipoatrophy in children with type 1 diabetes: an increasing incidence? J Diabetes Sci Technol 9(2):206\u2013208","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"324_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1055\/s-2001-18991","volume":"109","author":"K Raile","year":"2001","unstructured":"Raile K, Noelle V, Landgraf R, Schwarz HP (2001) Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp Clin Endocrino Diabetes 109(8):393\u20136","journal-title":"Exp Clin Endocrino Diabetes"},{"issue":"11","key":"324_CR11","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2337\/diacare.19.11.1283","volume":"19","author":"C Atlan-Gepner","year":"1996","unstructured":"Atlan-Gepner C, Bongrand P, Farnarier C, Xerri L, Choux R, Gauthier JF et al (1996) Insulin-induced lipoatrophy in type I diabetes. A possible tumor necrosis factor-alpha-mediated dedifferentiation of adipocytes. Diabetes Care 19(11):1283\u20135","journal-title":"Diabetes Care"},{"issue":"3","key":"324_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4103\/ijem.IJEM_63_20","volume":"24","author":"M Basu","year":"2020","unstructured":"Basu M, Pandit K, Banerjee M, Mondal SA, Mukhopadhyay P, Ghosh S (2020) Profile of auto-antibodies (disease related and other) in children with type 1 diabetes. Indian J Endocrinol Metab 24(3):256\u2013259","journal-title":"Indian J Endocrinol Metab"},{"issue":"Suppl 27","key":"324_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/pedi.12740","volume":"19","author":"FH Mahmud","year":"2018","unstructured":"Mahmud FH, Elbarbary NS, Frohlich-Reiterer E, Holl RW, Kordonouri O, Knip M et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes 19(Suppl 27):275\u2013286","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"324_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1159\/000351708","volume":"79","author":"B Salgin","year":"2013","unstructured":"Salgin B, Meissner T, Beyer P, Haberland H, Borkenstein M, Fussenegger J et al (2013) Lipoatrophy is associated with an increased risk of Hashimoto\u2019s thyroiditis and coeliac disease in female patients with type 1 diabetes. Horm Res Paediatr 79(6):368\u2013372","journal-title":"Horm Res Paediatr"},{"issue":"1083","key":"324_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/postgradmedj-2015-133639","volume":"92","author":"PP Chakraborty","year":"2016","unstructured":"Chakraborty PP, Biswas SN (2016) Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy. Postgrad Med J 92(1083):57\u201358","journal-title":"Postgrad Med J"},{"issue":"7","key":"324_CR16","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s001250051476","volume":"43","author":"G Jermendy","year":"2000","unstructured":"Jermendy G, Nadas J, Sapi Z (2000) \u201cLipoblastoma-like\u201d lipoatrophy induced by human insulin: morphological evidence for local dedifferentiation of adipocytes? Diabetologia 43(7):955\u2013956","journal-title":"Diabetologia"},{"issue":"3","key":"324_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2337\/dc07-1739","volume":"31","author":"X Lopez","year":"2008","unstructured":"Lopez X, Castells M, Ricker A, Velazquez EF, Mun E, Goldfine AB (2008) Human insulin analog\u2013induced lipoatrophy. Diabetes Care 31(3):442\u2013444","journal-title":"Diabetes Care"},{"issue":"1","key":"324_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2337\/diacare.24.1.174","volume":"24","author":"ME Griffin","year":"2001","unstructured":"Griffin ME, Feder A, Tamborlane WV (2001) Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause? Diabetes Care 24(1):174","journal-title":"Diabetes Care"},{"issue":"6","key":"324_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1464-5491.1993.tb00126.x","volume":"10","author":"E Chantelau","year":"1993","unstructured":"Chantelau E, Reuter M, Schotes S, Starke AA (1993) Severe lipoatrophy with human insulin: successfully treated by CSII. Diabet Med 10(6):580\u2013581","journal-title":"Diabet Med"},{"issue":"12","key":"324_CR20","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.2337\/dc13-1123","volume":"36","author":"EJ Phua","year":"2013","unstructured":"Phua EJ, Lopez X, Ramus J, Goldfine AB (2013) Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use. Diabetes Care 36(12):e204\u2013e205","journal-title":"Diabetes Care"},{"issue":"4","key":"324_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2337\/diacare.29.04.06.dc06-0004","volume":"29","author":"AJ Ramos","year":"2006","unstructured":"Ramos AJ, Farias MA (2006) Human insulin-induced lipoatrophy: a successful treatment with glucocorticoid. Diabetes Care 29(4):926\u2013927","journal-title":"Diabetes Care"},{"issue":"5","key":"324_CR22","first-page":"253","volume":"65","author":"J Beltrand","year":"2006","unstructured":"Beltrand J, Guilmin-Crepon S, Castanet M, Peuchmaur M, Czernichow P, Levy-Marchal C (2006) Insulin allergy and extensive lipoatrophy in child with type 1 diabetes. Horm Res 65(5):253\u2013260","journal-title":"Horm Res"},{"issue":"3","key":"324_CR23","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.diabres.2010.11.026","volume":"91","author":"D Peteiro-Gonzalez","year":"2011","unstructured":"Peteiro-Gonzalez D, Fernandez-Rodriguez B, Cabezas-Agricola JM, Araujo-Vilar D (2011) Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus. Diabetes Res Clin Pract 91(3):e61\u2013e63","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"324_CR24","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.2337\/dc16-2385","volume":"40","author":"A Kondo","year":"2017","unstructured":"Kondo A, Nakamura A, Takeuchi J, Miyoshi H, Atsumi T (2017) Insulin-induced distant site lipoatrophy. Diabetes Care 40(6):e67\u2013e68","journal-title":"Diabetes Care"},{"issue":"7","key":"324_CR25","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1210\/jc.2009-2773","volume":"95","author":"G Milan","year":"2010","unstructured":"Milan G, Murano I, Costa S, Pianta A, Tiengo C, Zulato E et al (2010) Lipoatrophy induced by subcutaneous insulin infusion: ultrastructural analysis and gene expression profiling. J Clin Endocrinol Metab 95(7):3126\u20133132","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"324_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1067\/mpd.2003.103","volume":"142","author":"EI Felner","year":"2003","unstructured":"Felner EI (2003) Human insulin-induced lipoatrophy. J Pediatr 142(4):448","journal-title":"J Pediatr"},{"issue":"1","key":"324_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archdermatol.2008.531","volume":"145","author":"L Valles","year":"2009","unstructured":"Valles L, Gonzalez M, Polo I, Enguita AB, Vanaclocha F, Ortiz-Romero PL (2009) Lipoatrophy associated with interferon alfa adjuvant therapy for melanoma. Arch Dermatol 145(1):98\u201399","journal-title":"Arch Dermatol"},{"key":"324_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40842-015-0013-5","volume":"1","author":"S Saberi","year":"2015","unstructured":"Saberi S, Esfandiari NH, MacEachern MP, Tan MH (2015) Detemir plus aspart and glulisine induced lipoatrophy: 2015 literature review and report of a new case. Clin Diabetes Endocrinol 1:10","journal-title":"Clin Diabetes Endocrinol"},{"issue":"2","key":"324_CR29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.2337\/dc19-1888","volume":"43","author":"T Turk Wensveen","year":"2020","unstructured":"Turk Wensveen T, FuckarCupic D, JurisicErzen D, Polic B, Wensveen FM (2020) Severe lipoatrophy in a patient with type 2 diabetes in response to human insulin analogs glargine and degludec: possible involvement of CD4 T cell-mediated tissue remodeling. Diabetes Care 43(2):494\u2013496","journal-title":"Diabetes Care"},{"issue":"1","key":"324_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00128071-200708010-00003","volume":"8","author":"RP Radermecker","year":"2007","unstructured":"Radermecker RP, Pierard GE, Scheen AJ (2007) Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol 8(1):21\u201328","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"324_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/lsm.22825","volume":"50","author":"T Lan","year":"2018","unstructured":"Lan T, Xiao Y, Tang L, Hamblin MR, Yin R (2018) Treatment of atrophic acne scarring with fractional micro-plasma radio-frequency in Chinese patients: a prospective study. Lasers Surg Med 50(8):844\u2013850","journal-title":"Lasers Surg Med"},{"issue":"7","key":"324_CR32","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/pedi.13094","volume":"21","author":"O Kordonouri","year":"2020","unstructured":"Kordonouri O, Biester T, Weidemann J, Ott H, Remus K, Grothaus J et al (2020) Lipoatrophy in children, adolescents and adults with insulin pump treatment: is there a beneficial effect of insulin glulisine? Pediatr Diabetes 21(7):1285\u20131291","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"324_CR33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/jama.1976.03260340045021","volume":"235","author":"TH Whitley","year":"1976","unstructured":"Whitley TH, Lawrence PA, Smith CL (1976) Amelioration of insulin lipoatrophy by dexamethasone injection. JAMA 235(8):839\u2013840","journal-title":"JAMA"},{"issue":"4","key":"324_CR34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2337\/diab.26.4.296","volume":"26","author":"O Kumar","year":"1977","unstructured":"Kumar O, Miller L, Mehtalia S (1977) Use of dexamethasone in treatment of insulin lipoatrophy. Diabetes 26(4):296\u2013299","journal-title":"Diabetes"},{"issue":"2","key":"324_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0190-9622(81)70017-3","volume":"4","author":"JP Callen","year":"1981","unstructured":"Callen JP (1981) Intralesional corticosteroids. J Am Acad Dermatol 4(2):149\u2013151","journal-title":"J Am Acad Dermatol"},{"key":"324_CR36","doi-asserted-by":"crossref","unstructured":"Sirithanabadeekul P, Tantrapornpong P, Rattakul B, Sutthipisal N, Thanasarnaksorn W (2021)\u00a0 Comparison of fractional picosecond 1064-nm laser and fractional carbon dioxide laser for treating atrophic acne scars: a randomized split-face trial.\u00a0Dermatol Surg 47(2):e58\u2013e65","DOI":"10.1097\/DSS.0000000000002572"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00324-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-021-00324-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00324-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T14:09:44Z","timestamp":1644242984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-021-00324-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["324"],"URL":"https:\/\/doi.org\/10.1007\/s42000-021-00324-z","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Scientific Committee of Children\u2019s Hospital P&A Kyriakou.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}